Overview

Tanezumab in Osteoarthritis of the Hip or Knee (2)

Status:
Completed
Trial end date:
2010-08-16
Target enrollment:
Participant gender:
Summary
Test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Naproxen
Tanezumab